Potential Price Increase for Celestica, Inc (CLS) After Recent Insider Activity

Celestica, Inc’s recently made public that its Former Officer Agrawal Alok K. acquired Company’s shares for reported $0.44 million on May 30 ’25. In the deal valued at $119.47 per share,3,672 shares were bought.

Then, Laurette Koellner bought 100,000 shares, generating $8,269,000 in total proceeds.

Before that, Laurette T Koellner bought 151,717 shares. Celestica, Inc shares valued at $13,945,827 were divested by the Director at a price of $91.92 per share.

JP Morgan initiated its Celestica, Inc [CLS] rating to an Overweight in a research note published on February 21, 2025; the price target was $166. CIBC also remained covering CLS and has increased its forecast on January 31, 2025 with a “Sector outperform” recommendation from previously “Neutral” rating. UBS started covering the stock on November 22, 2024. It rated CLS as “a Neutral”.

Price Performance Review of CLS

On Friday, Celestica, Inc [NYSE:CLS] saw its stock jump 1.68% to $152.67. Over the last five days, the stock has gained 12.90%. Celestica, Inc shares have risen nearly 173.55% since the year began. Nevertheless, the stocks have risen 65.41% over the past one year. While a 52-week high of $152.98 was reached on 06/27/25, a 52-week low of $40.25 was recorded on 04/04/25.

Levels Of Support And Resistance For CLS Stock

The 24-hour chart illustrates a support level at 149.79, which if violated will result in even more drops to 146.91. On the upside, there is a resistance level at 155.45. A further resistance level may holdings at 158.22.

How much short interest is there in Celestica, Inc?

A steep rise in short interest was recorded in Celestica, Inc stocks on 2025-06-13, growing by 0.12 million shares to a total of 4.05 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 3.94 million shares. There was a rise of 2.89%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on November 05, 2024 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $91 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.